To determine the role of sexual contact in transmission of Epstein-Barr virus (EBV) and occurrence of infectious mononucleosis (IM), a cross-sectional study was undertaken of EBV serologic testing and histories of IM and sexual behavior among 1006 new students at Edinburgh University. Prevalence of EBV seropositivity was significantly greater among women (79.2%) than among men (67.4%;
1960s, which firmly established EBV as the cause of IM [6] , most reports have been descriptive, and little is known about the detailed epidemiology of the virus. Because it is present in saliva, EBV is assumed (without direct evidence) to be spread among young adults through kissing. Two studies have reported EBV in male and female genital secretions [7, 8] , but evidence on whether the virus is spread by this route is very limited. One study has suggested that the spread of a rare strain of EBV (EBV type 2) among homosexual men is through sexual contact [9] , and a study of 98 Swedish teenaged girls gave evidence that EBV seropositivity was associated with previous sexual contact [10] . It is unclear, however, whether the risk among heterosexual individuals is related to age at first sexual intercourse or number of sex partners, and there is no information on whether this route of transmission can cause IM. This is a particularly important issue now that vaccines with the potential to prevent IM are being tested. The present study surveyed 11000 new university students to determine the relationship between sexual behavior and EBV infection in this population.
Subjects and Methods
Students who enrolled at the Edinburgh University Health Centre in October 1999 and who were enrolled in courses for which they would remain in Edinburgh for у4 years were invited to join the study. Most Edinburgh University courses last for у4 years, and the study was restricted to these students, because a major purpose is future follow-up of students who were initially EBV seronegative, to investigate risk factors for seroconversion. After reading an information sheet and discussing the study with one of the study coordinators, interested students were asked to sign a consent form.
All study participants were asked to complete an anonymous, confidential questionnaire about their lifestyles before attending the university. This included information about demographic factors and history of sexual behavior (numbers and sexes of partners, age at first sexual intercourse, and use of contraception), sexually transmitted diseases, and IM. A blood sample taken from each participant was used to test for serum IgG antibodies to EBV capsid antigen by a routine indirect immunofluorescence assay [11] .
Statistical analyses were conducted to investigate the relationship of each of the demographic and behavioral factors with the risk of EBV positivity and history of IM. Because these outcomes were not rare, calculation of odds ratios would give a biased estimate of relative risks, and, therefore, prevalence ratios were calculated instead, as the best estimate of relative risks [12] . The proportions of cases of IM and of asymptomatic seroconversion among sexually active students that were statistically attributable to sexual intercourse were determined by calculating the excess fraction (attributable risk percentage) [13] .
The prevalence ratios shown in the tables are based on prevalences within the entire study group, for simplicity and consistency. This may not always be the best measure of the effects of sexual factors on seroconversion, however, because many students will have seroconverted asymptomatically in childhood, before their first sexual intercourse, and therefore will not actually be at risk of seroconversion from sexual intercourse. To allow for examination of the effects on the study results of different assumptions about childhood asymptomatic seroconversion, we reanalyzed the risks of IM, excluding the silent seroconverters from the denominator (i.e., taking the extreme assumption that all silent seroconversion had occurred before the first sexual intercourse). These results are outlined in the text.
Adjustment for potential confounding was undertaken by Mantel-Haenszel stratification [14] . Ninety-five percent confidence intervals were Wald-based, and likelihood ratio tests for trend and heterogeneity were undertaken [14] . The calculations were done using the Stata statistical package [15] .
Results
In total, 1950 new students (800 men and 1150 women) who registered with the Edinburgh University Health Centre for the autumn term of 1999 were eligible for the study. Of these, 1006 (52%) agreed to take part in the study, completed a questionnaire, and gave a blood sample. Of the remainder, about half declined, and half were not asked to take part because of the hectic nature of the general practitioner registration procedure during the first few days of term. This gives an overall response rate of 68%. Three hundred and seventy-one participants were men, and 635 were women; 945 (94%) were !21 years old, and 61 were у21 years old.
Overall, 753 students were EBV seropositive, and 253 were EBV seronegative. Of the EBV-seropositive students, 110 had a history of IM, and 643 had no such history. Ten of the EBVseronegative students stated that they had a history of IM. The risk of being EBV seropositive was highly significantly greater among women, compared with men, with a greater likelihood of both IM and asymptomatic seroconversion among women (table 1) . Adjustment for number of sex partners (data not shown) left these results virtually unchanged. For both men and women, there was a tendency, although not significant, for EBV positivity to be more prevalent at older ages.
Fifty-seven percent of men and 58% of women had been sexually active before coming to the university (data not shown). There was also similarity between the sexes in the age at first sexual intercourse and in the number of partners. Results for risk relative to sexual intercourse were similar for both men and women, and, therefore, both are combined in the analyses below.
Risks of EBV seropositivity overall, asymptomatic seroconversion, and IM were highly significantly greater among students who had ever been sexually active (table 2) . Risks of EBV seropositivity were similar for heterosexual students and for those who were homosexual or bisexual, although there were wide confidence intervals for the latter groups. There was a complete absence of IM among homosexual students. On the basis of the likelihood ratio test, there was significant heterogeneity in risk of IM by sex of partner, although this must be interpreted cautiously because of the zero value in one of the cells in table 2. The proportions of cases of IM and of asymp- tomatic seroconversion among sexually active students statistically attributable to sexual intercourse were 67% and 11%, respectively (calculated from data presented in table 2, as described in Subjects and Methods).
The risk of EBV seropositivity was somewhat reduced ( ) among students who stated that they had always had P p .08 sexual intercourse protected by a condom, compared with those who often had unprotected sex (table 2) . Adjusting the analyses of condom use for number of sex partners left the results virtually unaltered (data not shown).
There was some indication of an increase in EBV seropositivity with younger age at first sexual intercourse, and there was a significant trend in this direction for IM (table 3). The risk of seropositivity was highly significantly related to number of sex partners (table 3) , and, again, this was more clearly present for IM than for asymptomatic seroconversion. The analyses shown are for heterosexual students; there were too few homosexual and bisexual students to conduct separate analyses for these groups. Adjusting the results on age at first sexual intercourse for number of sex partners reduced the significance of the trend in risk of IM from to P p .04 P p .18 (data not shown). Similarly, adjustment of number of sex partners for age at first sexual intercourse reduced the trend in risk of IM from to and the trend in risk of EBV P p .02 P p .08 seropositivity from to . Repetition of the P p .001 P p .002 analyses of risk of IM in relation to number of sex partners and age at first sexual intercourse, with exclusion of seronegative subjects from the denominator (see Subjects and Methods), produced stronger trends than those seen without this exclusion; relative risks were 5.31 for first sexual intercourse at age !16 years and 5.89 for у5 sex partners ( and P p .02 , for the respective trends in risk; data not shown). P p .002 Examination of the percentage prevalence of EBV seronegativity in table 3 in relation to number of sex partners shows, although not consistently, a ∼30% reduction in seronegativity for each additional sex partner.
The questionnaire asked about long-term sexual relationships (i.e., those у1 year in duration), as well as about any other sexual relationships. Among students who had had any sexual intercourse, the risk of EBV positivity was unrelated to the number of long-term relationships, both in crude analyses and in those adjusted for number of short-term relationships. When risks of EBV positivity were examined in relationship to cross-tabulated categories of number of sex partners and age at first sexual intercourse (table 4), both prevalences and relative risks increased with number of sex partners within each age stratum, but prevalences and relative risks for age at first sexual intercourse showed less consistent trends.
Discussion
EBV is a ubiquitous herpesvirus that is of clinical importance because of its association with IM and with a variety of human tumors. The frequency of IM and the high morbidity and mortality on a worldwide scale of EBV-associated malignancies make EBV a prime target for a vaccine to prevent primary infection. However, recent detailed information on the epidemiology of the virus, which is needed to plan a logical vaccine strategy, is lacking.
A previous study undertaken in the United Kingdom in the 1970s showed 2 peaks of EBV seroconversion, one at ages 6-7 years and another at ages 14-15 years [16, 17] . Although it has been suggested that the first peak of infection is due to virus spread by family members and the second due to virus spread through sexual contact, there is very limited evidence to support this supposition. One recent study showed that EBV type 2 infection, which accounts for only 1%-3% of infections in the general population, is related to sexual intercourse among homosexual men [9] . A second study showed an association between EBV seroconversion and previous sexual activity in 98 teenaged girls in Sweden [10] . Our study was undertaken to gain up-to-date epidemiology, including more-detailed information on the role of sexual contact in EBV transmission, and information on risk factors for IM in a group of 1006 university students.
Because a cohort study from early childhood is not practical, the retrospective cross-sectional design of the present study is the only feasible alternative. However, this leads to the possibility that information may be inaccurate through recall. Although this may have led to underestimation of risk associated with sexual intercourse, such misclassification is likely to have been nondifferential (i.e., not of a different nature in serologically EBV-seropositive, compared with EBV-seronegative, individuals), especially since the students did not know their EBV serostatus. Misclassification of this type leads to dilution of true risks, not inflation or creation of them [13] . The major outcome examined in the study, EBV serological status, was a laboratory measure, not a recall variable. The information on the other outcome variable, IM, did originate from recall, but the findings were supported by the serologic test results, so could not be simply a recall artifact; for this variable, too, recall errors would be expected to be nondifferential and so to have led to underestimation, not inflation, of associations. Our ∼68% response rate among eligible students who were approached to take part in the study is reasonably high for a study involving venepuncture and recruiting from a noninstitutionalized, healthy population. Again, this is likely to have been nondifferential and hence not to have led to artifactual associations, especially since EBV serostatus was unknown to respondents and nonrespondents alike.
We found a highly significant association between sexual intercourse and EBV seropositivity, with a correlation with increasing numbers of sex partners. These data strongly suggest that sexual contact, or a factor closely associated with it, is an important factor in acquisition of EBV during the teenage years. Because EBV has been found in genital secretions from healthy seropositive men and women [7, 8] , direct spread of virus during sexual intercourse is possible. It is very difficult, however, to distinguish between this and transmission of virus by kissing or orogenital contact during sexual intercourse, and, therefore, an indirect association remains a possibility. Our results show some evidence of a reduction in risk with condom use, which would accord with a direct route of transmission, but the results are not clear cut and need repetition. It seems implausible that the association with sexual intercourse could be explained by confounding factors; certainly, there is no known nonsexual etiological factor that could provide such an explanation.
The increasing risk of seropositivity with increasing number of sex partners would accord with a fixed risk per partner of ∼30% (see Results) . This suggests that, on a statistical basis, only in about half of instances does sexual intercourse with an infected person lead to seroconversion. If EBV seropositive partners infallibly transmitted the virus, then each new partner should give a risk equivalent to the prevalence of seropositivity among persons of that age (or perhaps greater, because partners would, on average, have had more sexual experience than would random persons of the same age), which would be ∼60% [16, 17] . The analyses of risk in relationship to long-term sexual relationships suggested that risk of infection by an EBV-positive partner is not increased by greater numbers of episodes of sexual intercourse.
The relationship of risk of IM to age at first sexual intercourse is less clear. Without adjustment for number of sex partners, the relationship was just significant; after adjustment, it was not significant, so it may simply reflect confounding by number of sex partners as the true risk factor. In cross-tabulations by both factors, there was mixed evidence of an independent effect of age at first sexual intercourse. If there is an effect, it would be reminiscent of the relationship between the sexually transmitted papilloma virus and cervical cancer and might be due to greater susceptibility for exposures occurring at younger ages. A larger study is needed to clarify whether age at first sexual intercourse is an independent risk factor.
The increase, in percentage point terms, in prevalence of a history of IM with increasing numbers of sex partners (e.g., increasing by 7.2% from 0 partners [5.0%] to 1 partner [12.2%], and by 4.6% from 1 partner [12.2%] to 2-4 partners [16.8%]; table 3) was somewhat greater than the corresponding increase in prevalence of a history of asymptomatic seroconversion, implying that a slight majority of seroconversions due to sexual intercourse are symptomatic. The 63.7% prevalence of seropositivity in students who had never had sexual intercourse is presumably largely or entirely a consequence of seroconversion in childhood. It is somewhat higher than the 45%-50% seropositivity at ages 10-12 years found in Britain in the 1970s [16, 17] ; perhaps childhood seroconversion has become more common over time, or some seroconversion unconnected with sexual intercourse may occur at older ages. It seems unlikely that there were appreciable numbers of students who had had sexual intercourse but replied that they had not; the replies in the questionnaires seemed to be very frank, and this is our experience of the students.
We calculated prevalences of EBV and IM history status in relation to the whole student group as the denominator, but it is arguable whether this provides the best assessment of the effect of intercourse on these factors. Ideally, the analyses would be restricted to individuals who had not seroconverted in childhood and, therefore, were at risk of seroconversion as a consequence of sexual behavior. Previous studies [16, 17] indicate that ∼50% of individuals in Britain seroconvert by age 12 years, almost all without clinical illness. Thus, it is probable that many seropositive individuals, if their serological status before their first sexual intercourse had been known, should not have been included in the denominator for the analyses.
Removal of these childhood seroconvertors from the analysis, however, would be likely to increase the associations shown in the tables, as illustrated by the reanalyses of IM risk shown in Results. The prevalence of seropositivity at entry to university was significantly greater among women than among men, a difference not explained by age at first sexual intercourse or number of sex partners. It might be related to the fact that women tend to have sexual relationships with men older than themselves; for those who have sexual intercourse before university entrance, this might make them more likely to have seropositive partners who would be able to transmit the virus. The deficit of IM in homosexual students, with evidence of heterogeneity in risk by sex of partner, is based on small numbers, but raises the possibility that clinical severity of infection may be affected by the sex of the partner, because there was not a substantial deficit of overall seropositivity among homosexual men.
The corollary of the finding that sexual contact is associated with spread of EBV is that lack of previous sexual experience is a risk factor for EBV seronegativity. Indeed, among women, three-quarters of seronegative students had never had intercourse. To reach adult levels of seropositivity in the United Kingdom, ∼90% of seronegative students will be infected with EBV while at university, and ∼45%-65% of these will develop IM [2, 3] . Therefore, this group could benefit from a vaccine that prevents primary EBV infection.
